The effect of human proinsulin C-peptide on erythrocyte deformability in patients with Type I diabetes mellitus

Diabetologia

Volumn 42, Issue 4, 1999, Pages 465-471

  Kunt, T ^a   Schneider, S ^b   Pfutzner A ^b   Goitum, K ^b   Engelbach, M ^b   Schauf, B ^b   Beyer, J ^b   Forst, T ^b  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b NONE

Author keywords

Erythrocyte deformability; Laser diffractoscopy; Microcirculation; Proinsulin C peptide; Shear stress

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); C PEPTIDE;

ARTICLE; BLOOD SAMPLING; DISULFIDE BOND; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; ERYTHROCYTE DEFORMABILITY; FEEDBACK SYSTEM; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; MICROCIRCULATION; PRIORITY JOURNAL; PROTEIN FOLDING; SHEAR STRESS;

C-PEPTIDE; DIABETES MELLITUS, TYPE 1; ENZYME INHIBITORS; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTES; HUMANS; LASERS; NA(+)-K(+)-EXCHANGING ATPASE; OUABAIN;

EID: 0032977914     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051180     Document Type: Article

References (46)

1. Rubenstein AH, Clark JL, Melani F, Steiner DF (1969) Secretion of proinsulin C-peptide by pancreatic beta cells and its circulation in blood. Nature 224: 697-699
2. Steiner DF (1978) On the role of proinsulin C-peptide. Diabetes 27 [Suppl] 145-148
3. Steiner DF, Oyen PE (1967) The biosynthesis of insulin and a probable precursor of insulin by a human islet cell adenoma. Proc Natl Acad Sci USA 57: 473-480
4. Kitabchi AE (1970) The biological and immunological properties of pork and beef insulin, proinsulin, and connecting peptides. J Clin Invest 49: 979-987
5. Hoogwerf BJ, Bantle JP, Gaenslen HE (1986) Infusion of synthetic human C-peptide does not effect plasma glucose, serum insulin, or plasma glucagon in healthy subjects. Metabolism 35: 122-125
6. Wahren J, Johansson BL (1998) New aspects of C-peptide physiology. Horm Met Res 30:A2-A5
7. Cohen P, Barzilai N, Karnieli E (1995) Suppression of insulin secretion by C-peptide infusions in humans. Isr J Med Sci 31: 284-288
8. Johansson BL, Linde B, Wahren J (1992) Effects of C-peptide on blood flow, capillary diffusion capacity and glucose utilization in the exercising forearm of type 1 (insulin-dependent) diabetic patients. Diabetologia 35: 1151-1158
9. Zierath JR, Galuska D, Johansson BL, Wallberg-Henriksson H (1991) Effect of human C-peptide on glucose transport in in vitro incubated skeletal muscle. Diabetologia 34: 899-901
10. Johansson BL, Sjöberg S, Wahren J (1992) The influence of human C-peptide on renal function and glucose utilisation in type 1 (insulin dependent) diabetic patients. Diabetologia 35: 121-128
11. Johansson BL, Kernell A, Sjöberg S, Wahren J (1993) Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1. J Clin Endocrinol Metab 77: 976-981
12. Johansson BL, Borg K, Fernqvist-Forbes E, Odergren T, Remahl S, Wahren J (1996) C-peptide improves autonomic nerve function in patients with type 1 diabetes. Diabetologia 39: 687-695
13. Forst T, Kunt T, Pohlmann T et al. (1998) Biological activity of C-peptide on the skin microcirculation in patients with insulin-dependent diabetes mellitus. J Clin Invest 101: 2036-2041
14. Kunt T, Forst T, Lehmann R et al. (1998) Human C-peptide increases calcium influx into endothelial cells. Diabetes 47 [Suppl] A30
15. Bareford D, Jennings PE, Stone PCW, Baar S, Barnett AH, Stuart J (1986) Effects of hyperglycemia and sorbitol accumulation on erythrocyte deformability in diabetes mellitus. J Clin Pathol 39: 722-727
16. +)ATPase activity in type 1 (insulin-dependent) diabetic subjects and its activation by homologous plasma. Diabetologia 29: 623-628
17. Chimori K, Miyazaki S, Kosaka J, Sakanaka A, Yasuda K, Miura K (1986) Increased sodium influx into erythrocytes in diabetes mellitus and hypertension. Clin Exp Theory Practice A8(2):185-199
18. Cohen NS, Ekholm JE, Luthra ME, Hanahan W (1976) Biochemical characterization of density-separated human erythrocytes. Biochim Biophys Acta 419: 229-242
19. McMillan DE, Utterback NG, La Puma J (1978) Reduced erythrocyte deformability in diabetes. Diabetes 27: 895-901
20. Ernst E, Matrai A (1986) Altered red and white blood cell rheology in type II diabetes. Diabetes 35: 1412-1415
21. Baba Y, Kai M, Kamada T, Setoyama S, Otsuji S (1979) Higher levels of erythrocyte membrane microviscosity in diabetes. Diabetes 28: 1138-1140
22. Schmid-Schönbein H, Volger E (1976) Red-cell aggregation and red cell deformability in diabetes. Diabetes 25: 897-902
23. King GL, Brownlee M (1996) The cellular and molecular mechanisms of diabetic complications. Endocrinol Metab Clin North Am 25: 255-270
24. Bailey AJ, Robins SD, Tanner WA (1976) Reducible components in the proteins of human erythrocyte membrane. Biochim Biophys Acta 434: 51-57
25. Rabini RA, Petruzzi E, Staffoani R et al. (1997) Diabetes mellitus and subjects' aging: a study on the ATP content and the ATP-related enzyme activities in human erythrocytes. Eur J Clin Invest 27: 327-332
26. Persson SU, Wohlfahrt G, Larsson H, Gustafson A (1996) Correlations between fatty acid composition of the erythrocyte membrane and blood rheology data. Scand J Clin Lab Invest 56: 183-190
27. Flieger R, Grabe R (1997) Cell-elastometry: a new method to measure erythrocyte membrane elasticity. Biorheology 34: 223-234
28. Kohno M, Murakawa K, Yasunari K et al. (1997) Improvement of erythrocyte deformability by cholesterol-lowering therapy with pravastatin in hypercholesterolemic patients. Metabolism 46: 287-291
29. Baskurt OK, Gelmont D, Meiselmann HJ (1998) Red blood cell deformability in sepsis. Am J Respir Crit Care Med 157: 421-427
30. Tooke JE (1995) Microvascular function in human diabetes. Diabetes 44: 721-726
31. Corbin DOC, Young RJ, Morrison DC et al. (1987) Blood flow in the foot, polyneuropathy and foot ulceration in diabetes mellitus. Diabetologia 30: 468-473
32. Bennaroch EE, Low PA (1991) The acetylcholine-induced flare response in evaluation of small fibre dysfunction. Ann Neurol 29: 590-595
33. Ruggiero D, Lecomte M, Michaud E, Lagarde M, Wiernsberger N (1997) Involvement of cell-cell interactions in the pathogenesis of diabetic retinopathy. Diabetes Metab 23: 30-42
34. Kunt T, Forst T, Harzer OJ et al. (1998) The influence of advanced glycation endproducts (AGE) on the expression of human endothelial adhesion molecules. Exp Clin Endocrinol Diabetes 106: 183-188
35. Chien S (1987) Red cell deformability and its relevance to blood flow. Ann Rev Physiol 49: 177-192
36. Sarrat P, Serise JM, Freyburger G, Lorient-Roudaut MF, Boisseau MR (1987) Hemorheologic study of different forms of vasomotor acrosyndromes. J Mal Vase 12: 113-116
37. Schut NH, van Arkel EC, Hardeman MR, Bilo HJG, Michels RPJ, Vreeken J (1993) No decreased erythrocyte deformability in type 1 (insulin-dependent) diabetes, either by filtration or by ektacytometry. Acta Diabetol 30: 89-92
38. +ATPase activity in synergism with neuropeptide Y Diabetologia 39: 199-205
39. +ATPaSe activity of renal tubule segments. Diabetologia 41: 287-291
40. Sjöberg S, Gunnarson R, Gjötterberg M, Persson A, Östman J (1987) Residual insulin production and prevalence of microvascular lesions and polyneuropathy in long-term type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30: 208-213
41. Kernell A, Ludvigsson J, Finnström K (1990) Vitreous fluorophotometry in juvenile diabetics with and without retinopathy in relation to metabolic control: insulin antibodies and C-peptide levels. Acta Ophthalmol Scand 68: 415-420
42. Dufayet De La Tour D, Raccah D, Jannot MF, Coste T, Rougerie C, Vague P (1998) Erythrocyte Na/K ATPase activity and diabetes: relationship with C-peptide level. Diabetologia 41: 1080-1084
43. + transport in diabetes mellitus. Diabetes 39: 850-854
44. 2+ and calmodulin. J Clin Invest 82: 394-400
45. Schischmanoff PO, Winardi R, Discher DE, Parra MK, Bicknese SE, Witkowska HE, Conboy JG, Mohandas N (1995) Defining of the minimal domain of protein 4.1 involved in spectrin-actin binding. J Biol Chem 270: 21243-50
46. Gardner K, Bennett V (1986) A new erythrocyte membrane-associated protein with calmodulin binding activity: identification and purification. J Biol Chem 261: 1339-1348